Scinomed Ltd - Accounts to registrar (filleted) - small 18.2

Scinomed Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.2.0.376 06509477 Board of Directors 1.1.20 31.12.20 31.12.20 true false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure065094772019-12-31065094772020-12-31065094772020-01-012020-12-31065094772018-12-31065094772019-01-012019-12-31065094772019-12-3106509477ns16:EnglandWales2020-01-012020-12-3106509477ns15:PoundSterling2020-01-012020-12-3106509477ns11:Director12020-01-012020-12-3106509477ns11:PrivateLimitedCompanyLtd2020-01-012020-12-3106509477ns11:SmallEntities2020-01-012020-12-3106509477ns11:AuditExempt-NoAccountantsReport2020-01-012020-12-3106509477ns11:SmallCompaniesRegimeForDirectorsReport2020-01-012020-12-3106509477ns11:SmallCompaniesRegimeForAccounts2020-01-012020-12-3106509477ns11:FullAccounts2020-01-012020-12-310650947712020-01-012020-12-3106509477ns11:Director22020-01-012020-12-3106509477ns11:CompanySecretary12020-01-012020-12-3106509477ns11:RegisteredOffice2020-01-012020-12-3106509477ns6:CurrentFinancialInstruments2020-12-3106509477ns6:CurrentFinancialInstruments2019-12-3106509477ns6:Non-currentFinancialInstruments2020-12-3106509477ns6:Non-currentFinancialInstruments2019-12-3106509477ns6:ShareCapital2020-12-3106509477ns6:ShareCapital2019-12-3106509477ns6:SharePremium2020-12-3106509477ns6:SharePremium2019-12-3106509477ns6:RetainedEarningsAccumulatedLosses2020-12-3106509477ns6:RetainedEarningsAccumulatedLosses2019-12-3106509477ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2020-01-012020-12-3106509477ns6:ComputerSoftware2020-01-012020-12-3106509477ns6:LeaseholdImprovements2020-01-012020-12-3106509477ns6:PlantMachinery2020-01-012020-12-3106509477ns6:FurnitureFittings2020-01-012020-12-3106509477ns6:ComputerEquipment2020-01-012020-12-3106509477ns6:IntangibleAssetsOtherThanGoodwill2019-12-3106509477ns6:IntangibleAssetsOtherThanGoodwill2020-01-012020-12-3106509477ns6:IntangibleAssetsOtherThanGoodwill2020-12-3106509477ns6:IntangibleAssetsOtherThanGoodwill2019-12-3106509477ns6:LeaseholdImprovements2019-12-3106509477ns6:PlantMachinery2019-12-3106509477ns6:FurnitureFittings2019-12-3106509477ns6:ComputerEquipment2019-12-3106509477ns6:LeaseholdImprovements2020-12-3106509477ns6:PlantMachinery2020-12-3106509477ns6:FurnitureFittings2020-12-3106509477ns6:ComputerEquipment2020-12-3106509477ns6:LeaseholdImprovements2019-12-3106509477ns6:PlantMachinery2019-12-3106509477ns6:FurnitureFittings2019-12-3106509477ns6:ComputerEquipment2019-12-3106509477ns6:CostValuation2019-12-3106509477ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-12-3106509477ns6:CurrentFinancialInstrumentsns6:WithinOneYear2019-12-3106509477ns6:Non-currentFinancialInstruments2020-01-012020-12-31
REGISTERED NUMBER: 06509477 (England and Wales)















SCINOMED LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2020






SCINOMED LTD (REGISTERED NUMBER: 06509477)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2020




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SCINOMED LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2020







DIRECTORS: Mr G Lane
Mr A P Lane





SECRETARY: Mrs S M Lane





REGISTERED OFFICE: Windsor House
Cornwall Road
Harrogate
HG1 2PW





REGISTERED NUMBER: 06509477 (England and Wales)





ACCOUNTANTS: DSC
Chartered Accountants
Tattersall House
East Parade
Harrogate
North Yorkshire
HG1 5LT

SCINOMED LTD (REGISTERED NUMBER: 06509477)

BALANCE SHEET
31 DECEMBER 2020

2020 2019
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 721,891 453,926
Tangible assets 5 711,342 16,320
Investments 6 1,812,845 1,812,845
3,246,078 2,283,091

CURRENT ASSETS
Stocks 1,122,529 1,332,878
Debtors 7 3,530,622 1,314,573
Prepayments and accrued income 2,984,016 1,879,365
Cash at bank and in hand 91,883 325,221
7,729,050 4,852,037
CREDITORS
Amounts falling due within one year 8 1,315,314 251,270
NET CURRENT ASSETS 6,413,736 4,600,767
TOTAL ASSETS LESS CURRENT
LIABILITIES

9,659,814

6,883,858

CREDITORS
Amounts falling due after more than one
year

9

(16,224,528

)

(13,328,548

)

ACCRUALS AND DEFERRED INCOME (574,947 ) (13,789 )
NET LIABILITIES (7,139,661 ) (6,458,479 )

CAPITAL AND RESERVES
Called up share capital 200,000 200,000
Share premium 315,000 315,000
Retained earnings (7,654,661 ) (6,973,479 )
SHAREHOLDERS' FUNDS (7,139,661 ) (6,458,479 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2020 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SCINOMED LTD (REGISTERED NUMBER: 06509477)

BALANCE SHEET - continued
31 DECEMBER 2020


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 September 2021 and were signed on its behalf by:





Mr G Lane - Director


SCINOMED LTD (REGISTERED NUMBER: 06509477)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2020

1. STATUTORY INFORMATION

Scinomed Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis which assumes that the support of the directors and other long term creditors will be maintained.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Amortisation is provided at the following annual rate in order to write off each asset over its estimated useful life.

Intellectual Property - 25% on cost

Research & development costs
Where research and development costs are capitalised, amortisation is provided at the following annual rate in order to write off each asset over its estimated useful life.

Research and development costs - between 10% and 20% on cost

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 10% on cost
Plant and machinery - 20% on cost
Fixtures and fittings - 10% on cost
Office Equipment - 25% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


SCINOMED LTD (REGISTERED NUMBER: 06509477)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2020

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2019 - 4 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 January 2020 649,466
Additions 350,392
At 31 December 2020 999,858
AMORTISATION
At 1 January 2020 195,540
Charge for year 82,427
At 31 December 2020 277,967
NET BOOK VALUE
At 31 December 2020 721,891
At 31 December 2019 453,926

SCINOMED LTD (REGISTERED NUMBER: 06509477)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2020

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Office
property machinery fittings Equipment Totals
£    £    £    £    £   
COST
At 1 January 2020 1,579 13,765 18,934 22,846 57,124
Additions - 831,261 - 5,326 836,587
At 31 December 2020 1,579 845,026 18,934 28,172 893,711
DEPRECIATION
At 1 January 2020 1,579 13,466 4,383 21,376 40,804
Charge for year - 138,439 1,585 1,541 141,565
At 31 December 2020 1,579 151,905 5,968 22,917 182,369
NET BOOK VALUE
At 31 December 2020 - 693,121 12,966 5,255 711,342
At 31 December 2019 - 299 14,551 1,470 16,320

6. FIXED ASSET INVESTMENTS
Shares in Interest
group in joint
undertakings venture Totals
£    £    £   
COST
At 1 January 2020
and 31 December 2020 29,832 1,783,013 1,812,845
NET BOOK VALUE
At 31 December 2020 29,832 1,783,013 1,812,845
At 31 December 2019 29,832 1,783,013 1,812,845

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2020 2019
£    £   
Trade debtors 673,271 54,406
Other debtors 2,857,351 1,260,167
3,530,622 1,314,573

Other debtors includes a loan made to Scinomed GmbH of £2,558,066 (2019: £1,239,237).

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2020 2019
£    £   
Trade creditors 944,123 34,473
Taxation and social security 164,661 6,841
Other creditors 206,530 209,956
1,315,314 251,270

SCINOMED LTD (REGISTERED NUMBER: 06509477)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2020

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2020 2019
£    £   
Other creditors 16,224,528 13,328,548

The loans are unsecured with no set repayment date. A market rate of interest is payable on the loans.

10. ULTIMATE CONTROLLING PARTY

The controlling party is International Investments II Limited, a company incorporated in Hong Kong.